Business Coach
9562
D. Western Therapeutics Institute
4576
Daiwa Cycle
5888
Liberta
4935
Artra Group
6029
(FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 12.33%1.74B | 12.22%394.84M | -22.17%385.88M | 25.39%442.14M | 48.24%517.58M | -2.48%1.55B | -38.31%351.84M | 42.78%495.79M | 4.18%352.61M | 4.91%349.15M |
Cost of revenue | 2.82%1.09B | 11.67%271.62M | -16.98%235.74M | -1.63%256.99M | 20.13%321.53M | 10.53%1.06B | -1.98%243.23M | 24.61%283.97M | 12.02%261.26M | 8.71%267.64M |
Gross profit | 32.69%654.56M | 13.44%123.22M | -29.12%150.13M | 102.68%185.15M | 140.53%196.06M | -22.11%493.29M | -66.29%108.62M | 77.49%211.82M | -13.18%91.35M | -5.90%81.51M |
Operating expense | -22.22%596M | -35.06%156.39M | -27.41%140.45M | -4.32%152.39M | -15.03%146.77M | 11.21%766.31M | 47.94%240.83M | 19.25%193.48M | -8.41%159.27M | -9.16%172.73M |
Operating profit | 121.45%58.56M | 74.91%-33.17M | -47.17%9.69M | 148.23%32.76M | 154.03%49.29M | -390.01%-273.01M | -182.95%-132.21M | 142.74%18.34M | 1.10%-67.92M | 11.89%-91.22M |
Net non-operating interest income (expenses) | -256.34%-6.1M | -66.61%-1.89M | -244.92%-1.29M | -1,851.90%-1.54M | -1,017.07%-1.37M | 75.96%-1.71M | -530.56%-1.14M | -59.15%-374K | 97.54%-79K | 96.48%-123K |
Non-operating interest income | ---- | ---- | 0.00%3K | 0.00%1K | 0.00%2K | ---- | ---- | -25.00%3K | -50.00%1K | -50.00%2K |
Non-operating interest expense | 256.34%6.1M | 66.96%1.89M | 242.97%1.29M | 1,828.75%1.54M | 1,000.80%1.38M | 78.79%1.71M | 564.12%1.13M | 77.00%377K | -69.58%80K | -59.81%125K |
Net investment income | -1,168.42%-241K | -27.59%126K | 97.53%-4K | 86.03%-19K | 367.69%174K | -390.91%-162K | ||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | 98.94%-4.93M | 13.71%-2.93M | 93.05%-1.4M | 0 | 65.79%-599K | -3,133.45%-464.74M | -314.67%-3.39M | -1,515.79%-20.17M | -15,724.13%-439.44M | 81.63%-1.75M |
Less:Other special charges | -49.53%4.93M | 299.86%2.93M | 27.60%1.4M | --0 | -65.79%599K | -32.07%9.76M | -10.51%732K | -12.02%1.1M | 122.61%6.18M | -81.63%1.75M |
Less:Write off | --0 | --0 | --0 | ---- | ---- | --454.98M | --2.66M | --19.07M | ---- | ---- |
Other non-operating income (expenses) | 79.23%-2.83M | 62.58%-6.5M | -14.00%1.54M | -172.47%-258K | 49.16%2.39M | -140.40%-13.63M | -19,631.46%-17.38M | 134.69%1.79M | 389.43%356K | 125.01%1.6M |
Income before tax | 105.94%44.7M | 71.21%-44.37M | 2,028.84%8.29M | 106.13%31.08M | 154.22%49.7M | -808.69%-753.1M | -197.10%-154.12M | 99.02%-430K | -577.24%-506.91M | 25.48%-91.65M |
Income tax | -234.70%-27.9M | -2,062.42%-27.73M | 932K | -89.73%2.84M | 52.88%-3.94M | 135.85%20.71M | -90.53%1.41M | 0 | -41.59%27.67M | 77.33%-8.37M |
Net income | 109.38%72.6M | 89.30%-16.64M | 1,812.09%7.36M | 105.28%28.24M | 164.41%53.64M | -744.22%-773.82M | -208.17%-155.53M | 98.42%-430K | -337.39%-534.58M | 3.24%-83.28M |
Net income continuous operations | 109.38%72.6M | 89.30%-16.64M | 1,812.09%7.36M | 105.28%28.24M | 164.41%53.64M | -744.22%-773.82M | -208.17%-155.53M | 98.42%-430K | -337.40%-534.58M | 3.24%-83.28M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | 109.38%72.6M | 89.30%-16.64M | 1,812.09%7.36M | 105.28%28.24M | 164.41%53.64M | -744.22%-773.82M | -208.17%-155.53M | 98.42%-430K | -337.39%-534.58M | 3.24%-83.28M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 109.38%72.6M | 89.30%-16.64M | 1,812.09%7.36M | 105.28%28.24M | 164.41%53.64M | -744.22%-773.82M | -208.17%-155.53M | 98.42%-430K | -337.39%-534.58M | 3.24%-83.28M |
Gross dividend payment | ||||||||||
Basic earnings per share | 109.37%29.07 | 89.29%-6.68 | 1,943.75%2.95 | 105.27%11.31 | 164.32%21.49 | -692.24%-310.4 | -198.75%-62.38 | 98.28%-0.16 | -312.56%-214.45 | 18.63%-33.41 |
Diluted earnings per share | 109.19%28.53 | 89.29%-6.68 | 1,740.80%2.83 | 105.19%11.14 | 163.27%21.14 | -692.24%-310.4 | -208.14%-62.38 | 98.45%-0.1725 | -312.56%-214.45 | 18.63%-33.41 |
Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |